Aelis Farma (FRA:69O) ROCE %: -37.31% (As of Dec. 2025)


FRA:69O Aelis Farma SA FRA:69O
32 GF Score
Price €1.04
GF Value €0.95
! 4 Warning Signs
View Full Analysis

What is Aelis Farma ROCE %?

Aelis Farma FRA:69O +1.17% 32 ROCE % is -37.31% as of Dec. 2025. GuruFocus rates FRA:69O with a GF Score™ of 32/100 and a GF Value™ of €0.95. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aelis Farma's annualized ROCE % for the quarter that ended in Dec. 2025 was -37.31%.

Aelis Farma  (FRA:69O) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aelis Farma ROCE % Related Terms

Aelis Farma ROCE % Historical Data

* Premium members only.

The historical data trend for Aelis Farma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma ROCE % Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only 19.47 -75.53 -24.77 -46.36 -49.85

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.57 -45.77 -51.50 -64.33 -37.31
FRA:69O
32GF Score
Aelis Farma SA FRA:69O
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma ROCE % Calculation

Aelis Farma's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-6.134/( ( (19.706 - 4.806) + (12.048 - 2.34) )/ 2 )
=-6.134/( (14.9+9.708)/ 2 )
=-6.134/12.304
=-49.85 %

Aelis Farma's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-3.89/( ( (15.579 - 4.433) + (12.048 - 2.34) )/ 2 )
=-3.89/( ( 11.146 + 9.708 )/ 2 )
=-3.89/10.427
=-37.31 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -37.31% mean?
Aelis Farma (FRA:69O) has a ROCE % of -37.31% as of Dec. 2025.
Is Aelis Farma's ROCE % too high?
Aelis Farma's current ROCE % is -37.31%. Overall, Aelis Farma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's ROCE % compare to VRTX and REGN?
Aelis Farma's ROCE % of -37.31% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Aelis Farma's current ROCE % is -37.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Aelis Farma (FRA:69O) has a current ROCE % of -37.31%. The stock's GF Value™ is €0.95, compared to a current price of €1.04 — trading 9.1% above its estimated fair value. The current ROCE % is -37.31%. Aelis Farma's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Aelis Farma (FRA:69O), the current ROCE % is -37.31% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (FRA:69O) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.04 is trading 9.1% above its estimated GF Value™ of €0.95.

Key valuation signals for FRA:69O:

  • ROCE %: -37.31%
  • GF Value™: €0.95 vs. price of €1.04 (9.1% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the FRA:69O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges AELIS:France
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
32GF Score

Get the complete analysis for FRA:69O

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price
€0.95
GF Value